These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 18367125

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prediction of extracapsular extension of prostate cancer based on systematic core biopsies.
    Tarján M, Tot T.
    Scand J Urol Nephrol; 2006; 40(6):459-64. PubMed ID: 17130097
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy.
    Scattoni V, Raber M, Abdollah F, Roscigno M, Dehò F, Angiolilli D, Maccagnano C, Gallina A, Capitanio U, Freschi M, Doglioni C, Rigatti P, Montorsi F.
    Eur Urol; 2010 Jan; 57(1):1-8. PubMed ID: 19720449
    [Abstract] [Full Text] [Related]

  • 10. Role of prostate biopsy schemes in accurate prediction of Gleason scores.
    Mian BM, Lehr DJ, Moore CK, Fisher HA, Kaufman RP, Ross JS, Jennings TA, Nazeer T.
    Urology; 2006 Feb; 67(2):379-83. PubMed ID: 16461089
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
    Sankin A, Tareen B, Lepor H.
    Prostate Cancer Prostatic Dis; 2009 Feb; 12(2):204-8. PubMed ID: 19238170
    [Abstract] [Full Text] [Related]

  • 13. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
    Capitanio U, Karakiewicz PI, Valiquette L, Perrotte P, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F.
    Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
    [Abstract] [Full Text] [Related]

  • 14. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
    Campos-Fernandes JL, Bastien L, Nicolaiew N, Robert G, Terry S, Vacherot F, Salomon L, Allory Y, Vordos D, Hoznek A, Yiou R, Patard JJ, Abbou CC, de la Taille A.
    Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Prostate biopsies: how many samples and how many containers? Cost effectiveness].
    Molinié V, Mahjoub WK, Balaton A.
    Ann Pathol; 2008 Oct; 28(5):424-8. PubMed ID: 19068397
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N, Lane BR, Li J, Moussa AS, Soriano M, Jones JS.
    J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.